Trifylli, E.-M.; Koustas, E.; Papadopoulos, N.; Sarantis, P.; Aloizos, G.; Damaskos, C.; Garmpis, N.; Garmpi, A.; Karamouzis, M.V.
An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma. Life 2022, 12, 665.
https://doi.org/10.3390/life12050665
AMA Style
Trifylli E-M, Koustas E, Papadopoulos N, Sarantis P, Aloizos G, Damaskos C, Garmpis N, Garmpi A, Karamouzis MV.
An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma. Life. 2022; 12(5):665.
https://doi.org/10.3390/life12050665
Chicago/Turabian Style
Trifylli, Eleni-Myrto, Evangelos Koustas, Nikolaos Papadopoulos, Panagiotis Sarantis, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, and Michalis V. Karamouzis.
2022. "An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma" Life 12, no. 5: 665.
https://doi.org/10.3390/life12050665
APA Style
Trifylli, E.-M., Koustas, E., Papadopoulos, N., Sarantis, P., Aloizos, G., Damaskos, C., Garmpis, N., Garmpi, A., & Karamouzis, M. V.
(2022). An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma. Life, 12(5), 665.
https://doi.org/10.3390/life12050665
